PURESPRING

• 72110 - Research and experimental development on biotechnology

Purespring is funded by leading biotech investors with a strong record of creating and building pioneering companies to transform patients' lives around the world and has raised £115M to date... At Purespring, we are leading a revolution in the treatment of kidney diseases. The main function of the kidneys is to filter water and waste products out of the blood to create urine. The main filtering units are the glomeruli, which are largely made up of podocytes... Purespring is developing gene therapies to halt or prevent kidney disease, one of humankind's most poorly treated disease areas.

Also known as: PURESPRING THERAPEUTICS LIMITED

Previous names: SYNCONA COLLABORATION (S) LIMITED

Registration numbers: 12543677 (CH)

Primary location: London United Kingdom